BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25539564)

  • 21. Removal of silicone oil with 25-gauge transconjunctival sutureless vitrectomy system.
    Kapran Z; Acar N
    Retina; 2007 Oct; 27(8):1059-64. PubMed ID: 18040245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early postoperative intraocular pressure stability after combined 23-gauge sutureless vitrectomy and cataract surgery in patients with proliferative diabetic retinopathy.
    Lee JY; Jeong HS; Lee DY; Sohn HJ; Nam DH
    Retina; 2012 Oct; 32(9):1767-74. PubMed ID: 22481480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel technique of tangential, circumferential, scleral tunnel in 20-gauge transconjunctival sutureless vitrectomy: optical coherence tomography-aided analysis of wound integrity and clinical outcome.
    Awan MA; Lyall DA; Koshy ZR
    Br J Ophthalmol; 2012 Feb; 96(2):193-6. PubMed ID: 21653213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silicone oil tamponade in 23-gauge transconjunctival sutureless vitrectomy.
    Oliveira LB; Reis PA
    Retina; 2007 Oct; 27(8):1054-8. PubMed ID: 18040244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of complications in 25-gauge transconjunctival sutureless vitrectomy based on the surgical indications.
    Amato JE; Akduman L
    Ophthalmic Surg Lasers Imaging; 2007; 38(2):100-2. PubMed ID: 17396688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of transconjunctival sutureless 25-gauge vitrectomy with silicone oil infusion.
    Riemann CD; Miller DM; Foster RE; Petersen MR
    Retina; 2007 Mar; 27(3):296-303. PubMed ID: 17460584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Removal of Densiron-68 with a 23-gauge transconjunctival vitrectomy system.
    Romano MR; Groenwald C; Das R; Stappler T; Wong D; Heimann H
    Eye (Lond); 2009 Mar; 23(3):715-7. PubMed ID: 19151654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease.
    Lakhanpal RR; Humayun MS; de Juan E; Lim JI; Chong LP; Chang TS; Javaheri M; Fujii GY; Barnes AC; Alexandrou TJ
    Ophthalmology; 2005 May; 112(5):817-24. PubMed ID: 15878061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for suture requirement and early hypotony in 23-gauge vitrectomy for complex vitreoretinal diseases.
    Küçük E; Yılmaz U; Zor KR; Kalaycı D; Sarıkatipoğlu H
    Int Ophthalmol; 2017 Aug; 37(4):989-994. PubMed ID: 27696087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sutureless limited vitrectomy for positive vitreous pressure in cataract surgery.
    Chalam KV; Gupta SK; Agarwal S; Shah VA
    Ophthalmic Surg Lasers Imaging; 2005; 36(6):518-22. PubMed ID: 16355960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreoretinal surgery using transconjunctival sutureless vitrectomy.
    Cho YJ; Lee JM; Kim SS
    Yonsei Med J; 2004 Aug; 45(4):615-20. PubMed ID: 15344201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
    Lee DY; Jeong HS; Sohn HJ; Nam DH
    Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Self-sealing, sutureless sclerotomy in pars plana vitrectomy].
    Schmidt J; Nietgen GW; Brieden S
    Klin Monbl Augenheilkd; 1999 Oct; 215(4):247-51. PubMed ID: 10572888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined phacoemulsification and sutureless 23-gauge pars plana vitrectomy for complex vitreoretinal diseases.
    Sisk RA; Murray TG
    Br J Ophthalmol; 2010 Aug; 94(8):1028-32. PubMed ID: 20519234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive silicone oil removal in 23-gauge transconjunctival vitrectomy.
    Cekiç O; Cakir M; Yilmaz OF
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):514-5. PubMed ID: 22074707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fifty consecutive cases of transconjunctival sutureless 23-gauge vitrectomy combined with phacoemulsification and IOL implantation.
    Hütz WW; Hoffmann P; Hengerer F
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):481-6. PubMed ID: 21919434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term outcomes of 23-gauge pars plana vitrectomy.
    Gupta OP; Ho AC; Kaiser PK; Regillo CD; Chen S; Dyer DS; Dugel PU; Gupta S; Pollack JS
    Am J Ophthalmol; 2008 Aug; 146(2):193-197. PubMed ID: 18547538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary 23-gauge transconjunctival sutureless vitrectomy for rhegmatogenous retinal detachment.
    Tsang CW; Cheung BT; Lam RF; Lee GK; Yuen CY; Lai TY; Lam DS
    Retina; 2008 Oct; 28(8):1075-81. PubMed ID: 18779713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two scleral incision techniques in 23-gauge transconjunctival vitrectomy.
    Unal M; Balikoglu M; Teke MY; Koklu G
    Ophthalmic Surg Lasers Imaging Retina; 2013 Nov; 44(6):572-6. PubMed ID: 24170120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of 20-gauge transconjunctival sutureless vitrectomy.
    Papaefthymiou I; Petropoulos IK; Mangioris G; Mendrinos E; Pournaras CJ
    Ophthalmologica; 2013; 230(4):207-14. PubMed ID: 24029384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.